Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Opus Genetics Inc shares valued at $163,419 were purchased by Gallagher Cam on Dec 29 ’25. At $1.97 per share, Gallagher Cam acquired 83,000 shares. The insider’s holdings grew to 83,000 shares worth approximately $0.17 million following the completion of this transaction.
Also, Gallagher Cam purchased 81,000 shares, netting a total of over 160,275 in proceeds. Following the buying of shares at $1.98 each, the insider now holds 1,891,430 shares.
Before that, Foundation Fighting Blindness had sold 4,000,000 shares from its account. In a trade valued at $8,600,000, the Director traded Opus Genetics Inc shares for $2.15 each. Upon closing the transaction, the insider’s holdings decreased to 4,000,000 shares, worth approximately $11.04 million.
As published in their initiating research note from B. Riley Securities on December 10, 2025, Opus Genetics Inc [IRD] has been a Buy and the price target has been revised to $9. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late November. As of October 29, 2025, Wedbush has initiated its “an Outperform” rating for IRD. Earlier on October 16, 2025, Chardan Capital Markets initiated its rating. Their recommendation was “a Buy” for IRD stock.
Analyzing IRD Stock Performance
On last trading session, Opus Genetics Inc [NASDAQ: IRD] rose 3.08% to $2.01. The stock’s lowest price that day was $1.9358, but it reached a high of $2.03 in the same session. Over the course of the year, Opus Genetics Inc shares have jumped approximately 70.34%. Shares of the company reached a 52-week high of $2.5900 on 12/10/25 and a 52-week low of $0.6500 on 04/10/25.
Support And Resistance Levels for Opus Genetics Inc (IRD)
According to the 24-hour chart, there is a support level at 1.9500, which, if violated, would cause prices to drop to 1.8900. In the upper region, resistance lies at 2.0500. The next price resistance is at 2.1000. RSI (Relative Strength Index) is 46.53 on the 14-day chart, showing neutral technical sentiment.
Is Opus Genetics Inc subject to short interest?
Stocks of Opus Genetics Inc saw a sharp rise in short interest on 2025-12-15 jumping by 0.25 million shares to 0.64 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 0.39 million shares. A jump of 39.24% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.09 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.09.
Which companies own the most shares of Opus Genetics Inc (IRD)?
In terms of Opus Genetics Inc share price expectations, FactSet research, analysts set an average price target of 7 in the next 12 months, up nearly 258.97% from the previous closing price of $1.95. Analysts anticipate Opus Genetics Inc stock to reach 7 by 2026, with the lowest price target being 7. On April 11, 2025, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $6.